Stock Research: Bio-Rad Laboratories

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Bio-Rad Laboratories

NYSE:BIO US0905722072
67
  • Value
    94
  • Growth
    9
  • Safety
    Safety
    71
  • Combined
    79
  • Sentiment
    43
  • 360° View
    360° View
    67
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Bio-Rad Laboratories develops, manufactures, and markets products for life science research and clinical diagnostics. It operates in the Life Science and Clinical Diagnostics industries. Its products are sold globally to hospital laboratories, diagnostic reference laboratories, and physician office laboratories. In the last fiscal year, the company had a market cap of $6784 million, profits of $1379 million, and revenue of $2567 million, with 7700 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 67 (better than 67% compared with alternatives), overall professional sentiment and financial characteristics for the stock Bio-Rad Laboratories are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Bio-Rad Laboratories. The consolidated Value Rank has an attractive rank of 71, which means that the share price of Bio-Rad Laboratories is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 71% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 94. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 43. Professional investors are more confident in 57% other stocks. The consolidated Growth Rank also has a low rank of 9, which means that the company is below average in terms of growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. 91 of its competitors have better growth. ...read more

more
Index
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 16-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 61 60 49
Growth
9 3 9 17
Safety
Safety
94 97 86 96
Sentiment
43 13 36 61
360° View
360° View
67 25 45 65
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
48 40 69 88
Opinions Change
50 8 50 50
Pro Holdings
n/a 31 24 65
Market Pulse
52 40 43 16
Sentiment
43 13 36 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
71 61 60 49
Growth
9 3 9 17
Safety Safety
94 97 86 96
Combined
79 64 50 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
34 32 47 10
Price vs. Earnings (P/E)
64 64 57 50
Price vs. Book (P/B)
90 84 85 100
Dividend Yield
1 1 1 1
Value
71 61 60 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
12 12 20 7
Profit Growth
22 26 34 68
Capital Growth
28 11 29 27
Stock Returns
53 51 27 55
Growth
9 3 9 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
58 60 62 82
Refinancing
73 70 63 49
Liquidity
54 64 63 81
Safety Safety
94 97 86 96

Similar Stocks

Discover high‑ranked alternatives to Bio-Rad Laboratories and broaden your portfolio horizons.

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.